MedTrace Logo

Comparison of Buprenorphine and Methadone - 3

NCT00000334 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2017-01-31

No results posted yet for this study

Summary

The purpose of this study is to compare agonist and antagonist profile associated with buprenorphine vs. methadone during opiate withdrawal.

Conditions

  • Opioid-Related Disorders

Interventions

DRUG

Buprenorphine

Sponsors & Collaborators

  • Washington D.C. Veterans Affairs Medical Center

    collaborator FED

  • National Institute on Drug Abuse (NIDA)

    lead NIH

Principal Investigators

  • Steven Deutsch, M.D. · Washington D.C. Veterans Affairs Medical Center

Study Design

Purpose
TREATMENT

Eligibility

Min Age
23 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-12-01
Primary Completion
2004-11-01
Completion
2005-01-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000334 on ClinicalTrials.gov